BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 28829399)

  • 21. From nodule to differentiated thyroid carcinoma: contributions of molecular analysis in 2012.
    Albarel F; Conte-Devolx B; Oliver C
    Ann Endocrinol (Paris); 2012 Jun; 73(3):155-64. PubMed ID: 22503804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of leptin and its receptor in thyroid carcinoma: distinctive prognostic significance in different subtypes.
    Fan YL; Li XQ
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):261-7. PubMed ID: 25158596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric Thyroid Cancer: Genetics, Therapeutics and Outcome.
    Bauer AJ
    Endocrinol Metab Clin North Am; 2020 Dec; 49(4):589-611. PubMed ID: 33153669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of advanced thyroid cancer with targeted therapies: ten years of experience.
    Viola D; Valerio L; Molinaro E; Agate L; Bottici V; Biagini A; Lorusso L; Cappagli V; Pieruzzi L; Giani C; Sabini E; Passannati P; Puleo L; Matrone A; Pontillo-Contillo B; Battaglia V; Mazzeo S; Vitti P; Elisei R
    Endocr Relat Cancer; 2016 Apr; 23(4):R185-205. PubMed ID: 27207700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytological Diagnoses Associated with Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features According to the Bethesda System for Reporting Thyroid Cytopathology: A Systematic Review and Meta-Analysis.
    Bongiovanni M; Giovanella L; Romanelli F; Trimboli P
    Thyroid; 2019 Feb; 29(2):222-228. PubMed ID: 30426887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
    Ito Y; Onoda N; Ito KI; Sugitani I; Takahashi S; Yamaguchi I; Kabu K; Tsukada K
    Thyroid; 2017 Sep; 27(9):1142-1148. PubMed ID: 28635560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on C-Cell Neuroendocrine Neoplasm: Prognostic and Predictive Histopathologic and Molecular Features of Medullary Thyroid Carcinoma.
    Jung CK; Agarwal S; Hang JF; Lim DJ; Bychkov A; Mete O
    Endocr Pathol; 2023 Mar; 34(1):1-22. PubMed ID: 36890425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
    Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
    Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How Many Papillae in Conventional Papillary Carcinoma? A Clinical Evidence-Based Pathology Study of 235 Unifocal Encapsulated Papillary Thyroid Carcinomas, with Emphasis on the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features.
    Xu B; Serrette R; Tuttle RM; Alzumaili B; Ganly I; Katabi N; Tallini G; Ghossein R
    Thyroid; 2019 Dec; 29(12):1792-1803. PubMed ID: 31452453
    [No Abstract]   [Full Text] [Related]  

  • 30. Updates on the Management of Thyroid Cancer.
    Araque KA; Gubbi S; Klubo-Gwiezdzinska J
    Horm Metab Res; 2020 Aug; 52(8):562-577. PubMed ID: 32040962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of pediatric differentiated thyroid cancer: An overview for the pediatric oncologist.
    Prasad PK; Mahajan P; Hawkins DS; Mostoufi-Moab S; Venkatramani R
    Pediatr Blood Cancer; 2020 Jun; 67(6):e28141. PubMed ID: 32275118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline stimulated thyroglobulin level as a good predictor of successful ablation after adjuvant radioiodine treatment for differentiated thyroid cancers.
    Fatima N; uz Zaman M; Ikram M; Akhtar J; Islam N; Masood Q; Zaman U; Zaman A
    Asian Pac J Cancer Prev; 2014; 15(15):6443-7. PubMed ID: 25124640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. False-positive staining of thyroglobulin distinguished from mixed medullary and follicular thyroid carcinoma by duplex in situ hybridization.
    Takeshima K; Ariyasu H; Uraki S; Morita S; Furukawa Y; Inaba H; Iwakura H; Doi A; Warigaya K; Murata SI; Enomoto K; Hotomi M; Akamizu T
    Endocr J; 2020 Oct; 67(10):1007-1017. PubMed ID: 32522910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy.
    Lubitz CC; Sadow PM; Daniels GH; Wirth LJ
    Thyroid; 2021 Oct; 31(10):1451-1462. PubMed ID: 33860688
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinicopathologic Characteristics and Postsurgical Follow-Up of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in the Postnomenclature Revision Era.
    Taneja C; Yip L; Morariu EM; Seethala R; Chiosea SI; Ohori NP; Carty SE; Nikiforova MN; Nikiforov YE; Karslioglu-French E
    Thyroid; 2022 Nov; 32(11):1346-1352. PubMed ID: 35876443
    [No Abstract]   [Full Text] [Related]  

  • 36. [Differentiated thyroid carcinoma: initial evaluation and follow-up].
    Golbert L; Wajner SM; Rocha AP; Maia AL; Gross JL
    Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):701-10. PubMed ID: 16444352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: Epidemiology and Long-Term Outcomes in a Strictly Defined Cohort.
    Chung R; Guan H; Ponchiardi C; Cerda S; Marwaha N; Yilmaz OH; Pinjic E; McAneny D; Lee SL; Drake FT
    Thyroid; 2021 Jan; 31(1):68-75. PubMed ID: 32539676
    [No Abstract]   [Full Text] [Related]  

  • 38. Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador.
    Solis-Pazmino P; Salazar-Vega J; Lincango-Naranjo E; Garcia C; Koupermann GJ; Ortiz-Prado E; Ledesma T; Rojas T; Alvarado-Mafla B; Carcamo C; Ponce OJ; Brito JP
    BMC Cancer; 2021 Jan; 21(1):42. PubMed ID: 33419403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review.
    Maghsoomi Z; Emami Z; Malboosbaf R; Malek M; Khamseh ME
    BMC Cancer; 2021 May; 21(1):579. PubMed ID: 34016077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.
    Maia AL; Siqueira DR; Kulcsar MA; Tincani AJ; Mazeto GM; Maciel LM
    Arq Bras Endocrinol Metabol; 2014 Oct; 58(7):667-700. PubMed ID: 25372577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.